[up] Up a level
Group by: Item Type | Date | No Grouping
Number of items: 2.

Bröckelmann, Paul J. ORCID: 0000-0001-9662-9900, Böll, Boris ORCID: 0000-0002-6432-0981, Molin, Daniel, Schneider, Gundolf ORCID: 0000-0001-6175-2554, Leppä, Sirpa ORCID: 0000-0002-8265-511X, Meissner, Julia, Kamper, Peter, Hutchings, Martin, Christensen, Jacob H., Schnetzke, Ulf, Fuchs, Michael ORCID: 0000-0003-3289-3272, Jablonski, Janina ORCID: 0009-0007-2811-4762, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Klapper, Wolfram ORCID: 0000-0001-7208-4117, Kobe, Carsten ORCID: 0000-0002-2909-0826, Borchmann, Peter ORCID: 0000-0003-3782-2158 and Fosså, Alexander ORCID: 0000-0002-4484-9319 (2025). Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced‐stage Hodgkin lymphoma in older patients. HemaSphere, 9 (8). pp. 1-5. Wiley. ISSN 2572-9241

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Basaran, Aylin, Bühnen, Ina, Fuchs, Michael ORCID: 0000-0003-3289-3272, von Tresckow, Bastian ORCID: 0000-0003-1410-4487, Rosenwald, Andreas, Hansmann, Martin-Leo, Bernd, Heinz-Wolfram, Borchmann, Peter ORCID: 0000-0003-3782-2158, Klapper, Wolfram ORCID: 0000-0001-7208-4117 and Hartmann, Sylvia ORCID: 0000-0003-3424-1091 (2025). Refining histopathological growth pattern-based risk group discrimination in nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group. Leukemia, 39 (7). pp. 1735-1743. Springer Nature. ISSN 0887-6924

This list was generated on Sat Jul 25 09:11:55 2026 CEST.